$REFI

Chicago Atlantic Real Estate Finance, Inc. (REFI): Results of Operations and Financial Condition

Chicago Atlantic Real Estate Finance, Inc. (REFI) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ea030117601ex99-1.htm PRESS RELEASE DATED AUGUST 11, 2026 Exhibit 99.1 Chicago Atlantic Real Estate Finance Announces Second Quarter 2026 Financial Results CHICAGO— (August 11, 2026) Chicago Atlantic Real Estate Finance, Inc. (NASDAQ: REFI, “Chicago Atlantic”, “REFI” or

Original reporting
Published Aug 11, 2026, 11:02 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 11, 2026, 11:03 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$REFI
Neutral
medium confidence
Mentioned
$REFI
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$REFINeutralMed
01

Why it matters

This 8-K updates Q2 2026 operating metrics (net interest income, net income, and expected credit loss benefit/provision) and adds two capital-market catalysts: a Koach second-lien note-linked equity issuance and the merger framework expected to close in Q4 2026 subject to approvals.

02

Market read

Traders can reassess REFI’s near-term earnings trajectory from deployment timing and credit-loss movements, while also repricing deal and capital-structure risk from the Koach financing and the LIEN merger timeline.

03

What to watch

The Koach notes include a 2.5x exit fee and 12% aggregate interest with PIK component, which can affect future yield, refinancing risk, and investor perception of leverage and economics into the merger.

Relevance 7/10Novelty 7/10Timing: filed pre-market today, Q2 2026 results and deal updates

Background

REFI is a commercial mortgage REIT operating in a niche lending market and is pursuing a merger with Chicago Atlantic BDC, Inc. (LIEN).

Company-level read

Ticker impact

$REFINeutralMedium confidence
Context

REFI reported Q2 2026 results and disclosed $59.2M gross originations, plus a Koach private placement and the pending merger with LIEN.

Expected impact

Moderate two-sided reaction risk: positive from originations and portfolio performance language, offset by timing-driven earnings pressure and dilution/financing optics.

Evidence & confidence

The filing provides concrete quarterly income and credit-loss figures, and adds new financing (Koach) and a merger framework with expected Q4 2026 closing, which can shift valuation and risk premia.

Market effects

Adds datapoints on private-credit REIT lending performance, variable-rate exposure, and cannabis-adjacent collateral financing terms.

None explicit beyond company operations in Chicago.

Limited, company-specific capital markets and merger within US-listed mortgage/BDC complex.

Counterpoint

The “outlook remains positive” language may not offset near-term earnings volatility driven by deployment timing and early repayments, which can mask underlying credit or origination quality.

Key entities

  • Chicago Atlantic Real Estate Finance, Inc.

    Subject of the 8-K, reported Q2 2026 financial results and disclosed Koach transaction and pending merger.

  • Chicago Atlantic BDC, Inc.

    Affiliated BDC in the pending merger with REFI, expected to be the surviving company.

  • Koach Capital Fund I LLC, Koach Capital Fund II LP, Koach Capital Fund III LP

    Private placement investors providing second-lien promissory notes in exchange for REFI common stock.

Related articles

$REFIMed

Chicago Atlantic Real Estate Finance, Inc. Q2 2026 Earnings Call Summary

Chicago Atlantic Real Estate Finance (REFI) reported Q2 2026 distributable earnings of $0.44 per share, below the dividend, citing timing of $16.3 million in early loan prepayments. Management discussed a proposed merger with LIEN expected in Q4 2026, a Koach Capital cannabis sale-leaseback exposure, and a 90% to 100% payout target for 2026.

$CRWVMedAI 8/10

CoreWeave Has $104 Billion of Contracted Revenue and a $59 Billion Market Value

CoreWeave (NASDAQ: CRWV) reported Q2 results after the close. The company said its revenue backlog was about $104 billion as of June 30, up from $30.1 billion a year earlier. Q2 revenue rose 112% to $2.6 billion. Management guided 2026 revenue to $12.4 billion to $13.2 billion and raised 2026 capex to $35 billion to $39 billion. Shares rose about 19%.

$ICUMed

SeaStar Medical (ICU) Q2 2026 Earnings Call Transcript

SeaStar Medical Holding Corp (ICU) reported Q2 2026 net revenue of $615,000, up 82% year over year, and six-month net revenue of $1.1 million. Gross margin was 91%. Net loss was $3.7 million ($0.91/share). Cash was $7.0 million at June 30, 2026. QUELIMMUNE adoption reached 20 hospitals; NEUTRALIZE-AKI enrolled 223/339 patients.

$WYFIMedAI 8/10

WhiteFiber (WYFI) Q2 2026 Earnings Call Transcript

WhiteFiber (WYFI) reported Q2 2026 revenue of $28.8M, up 54%, driven by cloud services ($23.8M vs $16.6M) and new colocation at MTL 3 ($4.7M). Gross profit was $17.1M (59% margin). Net loss was $15M ($0.39/share); adjusted EBITDA $5.5M. Management cited $865M 10-year NC1 contract and financing progress.

$ECXMedAI 8/10

ECARX shares rise as Q2 revenue jumps 45% and losses narrow

ECARX Holdings Inc. (NASDAQ:ECX) shares rose premarket after Q2 results. For quarter ended June 30, revenue increased 45% YoY to $225.2M. Net loss narrowed to $12.0M, or -$0.03 per share. Gross margin rose to 19.8% and adjusted EBITDA turned positive at $0.5M. Company kept 2026 revenue guidance at $1.0B-$1.1B but warned memory costs may pressure margins.